

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | eosinophil chemotaxis (GO:0048245) | 9.42891421 |
| 2 | negative regulation by host of viral transcription (GO:0043922) | 8.48433508 |
| 3 | eosinophil migration (GO:0072677) | 8.48057878 |
| 4 | regulation of chronic inflammatory response (GO:0002676) | 8.36877501 |
| 5 | regulation of activation of Janus kinase activity (GO:0010533) | 8.00341524 |
| 6 | response to pheromone (GO:0019236) | 7.32274573 |
| 7 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 7.16906582 |
| 8 | negative regulation of T cell apoptotic process (GO:0070233) | 6.80148514 |
| 9 | regulation of mononuclear cell migration (GO:0071675) | 6.62327490 |
| 10 | macrophage chemotaxis (GO:0048246) | 6.52655629 |
| 11 | regulation of regulatory T cell differentiation (GO:0045589) | 6.51243505 |
| 12 | positive regulation of T cell apoptotic process (GO:0070234) | 6.34531809 |
| 13 | DNA deamination (GO:0045006) | 6.26195344 |
| 14 | regulation of T cell chemotaxis (GO:0010819) | 6.24670116 |
| 15 | positive regulation of T cell chemotaxis (GO:0010820) | 6.24670116 |
| 16 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 6.20750604 |
| 17 | positive regulation of monocyte chemotaxis (GO:0090026) | 6.19810579 |
| 18 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 6.17552855 |
| 19 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.07288723 |
| 20 | regulation of lymphocyte chemotaxis (GO:1901623) | 5.92396357 |
| 21 | regulation of macrophage chemotaxis (GO:0010758) | 5.91862118 |
| 22 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 5.81299368 |
| 23 | positive regulation of translational initiation (GO:0045948) | 5.57692221 |
| 24 | cellular response to interleukin-15 (GO:0071350) | 5.55193846 |
| 25 | positive thymic T cell selection (GO:0045059) | 5.49082434 |
| 26 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.23429222 |
| 27 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 5.17046716 |
| 28 | regulation of natural killer cell mediated immunity (GO:0002715) | 5.17046716 |
| 29 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 5.11774383 |
| 30 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 5.05812256 |
| 31 | response to interleukin-15 (GO:0070672) | 5.05456063 |
| 32 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.94366785 |
| 33 | dendritic cell chemotaxis (GO:0002407) | 4.94191401 |
| 34 | positive T cell selection (GO:0043368) | 4.94058162 |
| 35 | protein localization to synapse (GO:0035418) | 4.93645411 |
| 36 | modulation by host of viral transcription (GO:0043921) | 4.88946381 |
| 37 | modulation by host of symbiont transcription (GO:0052472) | 4.88946381 |
| 38 | negative regulation of viral transcription (GO:0032897) | 4.86513120 |
| 39 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.78293382 |
| 40 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.75741723 |
| 41 | monocyte chemotaxis (GO:0002548) | 4.71336792 |
| 42 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.66940509 |
| 43 | modulation of transcription in other organism involved in symbiotic interaction (GO:0052312) | 4.63145575 |
| 44 | presynaptic membrane assembly (GO:0097105) | 4.59150823 |
| 45 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.58595391 |
| 46 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 4.55881538 |
| 47 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.54904322 |
| 48 | positive regulation of dendritic spine development (GO:0060999) | 4.42205050 |
| 49 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.35629447 |
| 50 | positive regulation of lymphocyte migration (GO:2000403) | 4.35088935 |
| 51 | regulation of T cell apoptotic process (GO:0070232) | 4.33032505 |
| 52 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.29397397 |
| 53 | granulocyte activation (GO:0036230) | 4.29143113 |
| 54 | fatty acid elongation (GO:0030497) | 4.26247487 |
| 55 | thymic T cell selection (GO:0045061) | 4.23840813 |
| 56 | regulation of monocyte chemotaxis (GO:0090025) | 4.14694684 |
| 57 | negative regulation of protein localization to cell surface (GO:2000009) | 4.13770046 |
| 58 | ether lipid metabolic process (GO:0046485) | 4.12310409 |
| 59 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.08484330 |
| 60 | regulation of homotypic cell-cell adhesion (GO:0034110) | 4.08158001 |
| 61 | presynaptic membrane organization (GO:0097090) | 4.07936317 |
| 62 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 4.03793938 |
| 63 | diterpenoid biosynthetic process (GO:0016102) | 3.98462177 |
| 64 | myelin maintenance (GO:0043217) | 3.97720073 |
| 65 | negative regulation of viral genome replication (GO:0045071) | 3.97353146 |
| 66 | regulation of gamma-delta T cell activation (GO:0046643) | 3.96973809 |
| 67 | positive regulation of leukocyte apoptotic process (GO:2000108) | 3.96693535 |
| 68 | activated T cell proliferation (GO:0050798) | 3.96211282 |
| 69 | negative regulation of B cell proliferation (GO:0030889) | 3.92314307 |
| 70 | dendritic cell migration (GO:0036336) | 3.90523839 |
| 71 | regulation of T cell tolerance induction (GO:0002664) | 3.85600236 |
| 72 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.83586998 |
| 73 | neutrophil activation (GO:0042119) | 3.83269059 |
| 74 | positive regulation of cell killing (GO:0031343) | 3.79015238 |
| 75 | localization within membrane (GO:0051668) | 3.77419264 |
| 76 | positive regulation of smooth muscle cell migration (GO:0014911) | 3.76371486 |
| 77 | central nervous system myelination (GO:0022010) | 3.74933980 |
| 78 | axon ensheathment in central nervous system (GO:0032291) | 3.74933980 |
| 79 | response to methylmercury (GO:0051597) | 3.72218592 |
| 80 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.71872651 |
| 81 | T cell costimulation (GO:0031295) | 3.71344145 |
| 82 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.70423458 |
| 83 | T cell selection (GO:0045058) | 3.69989690 |
| 84 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.67435576 |
| 85 | lymphocyte costimulation (GO:0031294) | 3.67413697 |
| 86 | cytidine metabolic process (GO:0046087) | 3.66825365 |
| 87 | cytidine catabolic process (GO:0006216) | 3.66825365 |
| 88 | cytidine deamination (GO:0009972) | 3.66825365 |
| 89 | negative T cell selection (GO:0043383) | 3.64517955 |
| 90 | mechanosensory behavior (GO:0007638) | 3.63670895 |
| 91 | positive regulation of tolerance induction (GO:0002645) | 3.62024970 |
| 92 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.60913961 |
| 93 | modification by host of symbiont morphology or physiology (GO:0051851) | 3.56415264 |
| 94 | L-amino acid import (GO:0043092) | 3.54415522 |
| 95 | positive regulation of T cell migration (GO:2000406) | 3.52657889 |
| 96 | amino acid import (GO:0043090) | 3.51083764 |
| 97 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.49715076 |
| 98 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.49001342 |
| 99 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.48874436 |
| 100 | negative thymic T cell selection (GO:0045060) | 3.46592706 |
| 101 | regulation of calcium-mediated signaling (GO:0050848) | 3.46567244 |
| 102 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.45614464 |
| 103 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.45416114 |
| 104 | negative regulation of leukocyte apoptotic process (GO:2000107) | 3.44742347 |
| 105 | import into cell (GO:0098657) | 3.44477922 |
| 106 | regulation of protein kinase C signaling (GO:0090036) | 3.42122926 |
| 107 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.38615096 |
| 108 | regulation of lymphocyte migration (GO:2000401) | 3.38391288 |
| 109 | nucleoside diphosphate catabolic process (GO:0009134) | 3.38299713 |
| 110 | negative regulation of T cell differentiation (GO:0045581) | 3.35409875 |
| 111 | Golgi to endosome transport (GO:0006895) | 3.33355594 |
| 112 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.33150538 |
| 113 | regulation of cell killing (GO:0031341) | 3.33091120 |
| 114 | ear development (GO:0043583) | 3.27900067 |
| 115 | negative regulation of B cell activation (GO:0050869) | 3.27894415 |
| 116 | interaction with symbiont (GO:0051702) | 3.25965162 |
| 117 | asymmetric protein localization (GO:0008105) | 3.23890547 |
| 118 | negative regulation of T cell activation (GO:0050868) | 3.23179940 |
| 119 | positive regulation of B cell differentiation (GO:0045579) | 3.23023197 |
| 120 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.21510496 |
| 121 | regulation of interleukin-8 secretion (GO:2000482) | 3.20690068 |
| 122 | positive regulation of viral genome replication (GO:0045070) | 3.19079772 |
| 123 | T cell migration (GO:0072678) | 3.17704227 |
| 124 | regulation of lymphocyte apoptotic process (GO:0070228) | 3.17507495 |
| 125 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.16964980 |
| 126 | negative regulation of neurotransmitter transport (GO:0051589) | 3.16406113 |
| 127 | positive regulation of protein kinase C signaling (GO:0090037) | 3.12915447 |
| 128 | positive regulation of macrophage differentiation (GO:0045651) | 3.12130264 |
| 129 | regulation of protein glycosylation (GO:0060049) | 3.06985730 |
| 130 | auditory behavior (GO:0031223) | 3.06255127 |
| 131 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.02266379 |
| 132 | photoreceptor cell maintenance (GO:0045494) | 2.99623159 |
| 133 | digestive tract morphogenesis (GO:0048546) | 2.96421005 |
| 134 | apical protein localization (GO:0045176) | 2.95987869 |
| 135 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.94570254 |
| 136 | postsynaptic membrane organization (GO:0001941) | 2.94238592 |
| 137 | oligosaccharide catabolic process (GO:0009313) | 2.91770066 |
| 138 | positive regulation of protein homodimerization activity (GO:0090073) | 2.91452105 |
| 139 | vitamin biosynthetic process (GO:0009110) | 2.89864470 |
| 140 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.89788524 |
| 141 | nonmotile primary cilium assembly (GO:0035058) | 2.89771373 |
| 142 | establishment of endothelial barrier (GO:0061028) | 2.89466929 |
| 143 | regulation of beta-amyloid formation (GO:1902003) | 2.88863462 |
| 144 | regulation of bile acid biosynthetic process (GO:0070857) | 2.88487245 |
| 145 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.87509269 |
| 146 | nerve growth factor signaling pathway (GO:0038180) | 2.85659520 |
| 147 | coenzyme catabolic process (GO:0009109) | 2.84082573 |
| 148 | regulation of dendritic spine development (GO:0060998) | 2.80276269 |
| 149 | negative regulation of amino acid transport (GO:0051956) | 2.79314713 |
| 150 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.76596010 |
| 151 | intestinal cholesterol absorption (GO:0030299) | 2.76014312 |
| 152 | superoxide anion generation (GO:0042554) | 2.75985618 |
| 153 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.74306575 |
| 154 | positive regulation of synapse assembly (GO:0051965) | 2.70383251 |
| 155 | cellular potassium ion homeostasis (GO:0030007) | 2.69695679 |
| 156 | positive regulation of dendrite development (GO:1900006) | 2.67396104 |
| 157 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.65902185 |
| 158 | endothelial cell development (GO:0001885) | 2.64351006 |
| 159 | membrane raft organization (GO:0031579) | 2.61622943 |
| 160 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.61046811 |
| 161 | cellular protein complex localization (GO:0034629) | 2.60915694 |
| 162 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.60757705 |
| 163 | mannosylation (GO:0097502) | 2.60669788 |
| 164 | neuron cell-cell adhesion (GO:0007158) | 2.56922819 |
| 165 | biotin metabolic process (GO:0006768) | 2.56877274 |
| 166 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.55906693 |
| 167 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.54958151 |
| 168 | positive regulation of actin cytoskeleton reorganization (GO:2000251) | 2.53959443 |
| 169 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.53498279 |
| 170 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.53483743 |
| 171 | vocalization behavior (GO:0071625) | 2.53248769 |
| 172 | response to auditory stimulus (GO:0010996) | 2.52823039 |
| 173 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.50340471 |
| 174 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.49383894 |
| 175 | cell-cell junction maintenance (GO:0045217) | 2.49361316 |
| 176 | synaptic vesicle maturation (GO:0016188) | 2.49076017 |
| 177 | N-acetylglucosamine metabolic process (GO:0006044) | 2.46839365 |
| 178 | neurotransmitter uptake (GO:0001504) | 2.46722539 |
| 179 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.45315597 |
| 180 | eye photoreceptor cell differentiation (GO:0001754) | 2.44481923 |
| 181 | photoreceptor cell differentiation (GO:0046530) | 2.44481923 |
| 182 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.44092537 |
| 183 | neuronal action potential propagation (GO:0019227) | 2.42493888 |
| 184 | respiratory burst (GO:0045730) | 2.42155907 |
| 185 | cofactor catabolic process (GO:0051187) | 2.41930761 |
| 186 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.40885930 |
| 187 | response to lipoprotein particle (GO:0055094) | 2.40014088 |
| 188 | nucleotide transmembrane transport (GO:1901679) | 2.39279766 |
| 189 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.37877154 |
| 190 | cellular response to cholesterol (GO:0071397) | 2.37621085 |
| 191 | retina layer formation (GO:0010842) | 2.37267998 |
| 192 | cellular anion homeostasis (GO:0030002) | 2.36245808 |
| 193 | cell junction maintenance (GO:0034331) | 2.34566091 |
| 194 | inositol phosphate-mediated signaling (GO:0048016) | 2.33930564 |
| 195 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.33836390 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 6.05160573 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.41959680 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.53296969 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.43505369 |
| 5 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.20940764 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.14062099 |
| 7 | MYB_26560356_Chip-Seq_TH2_Human | 3.07943388 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.94715753 |
| 9 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.93496348 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.76673347 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.75591117 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.61105846 |
| 13 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.54271715 |
| 14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.53908589 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.43163385 |
| 16 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.42357902 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.39289063 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.39023509 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.31013844 |
| 20 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.29869767 |
| 21 | UTX_26944678_Chip-Seq_JUKART_Human | 2.29849672 |
| 22 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.28186464 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 2.27238980 |
| 24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.25657254 |
| 25 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.24176806 |
| 26 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19978534 |
| 27 | VDR_22108803_ChIP-Seq_LS180_Human | 2.19523617 |
| 28 | MAF_26560356_Chip-Seq_TH2_Human | 2.17386109 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.16471169 |
| 30 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.14834683 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.12341335 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.10438868 |
| 33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.07302578 |
| 34 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.06763002 |
| 35 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.06312790 |
| 36 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.04352221 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 2.03837659 |
| 38 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.94231534 |
| 39 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.94199225 |
| 40 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.94199225 |
| 41 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.92792358 |
| 42 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89580594 |
| 43 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.89389004 |
| 44 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.86156331 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.84261565 |
| 46 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.84052089 |
| 47 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.82837008 |
| 48 | GATA3_26560356_Chip-Seq_TH2_Human | 1.82263151 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81924227 |
| 50 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.80450001 |
| 51 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.72470105 |
| 52 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.72068121 |
| 53 | MAF_26560356_Chip-Seq_TH1_Human | 1.70529417 |
| 54 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.67368829 |
| 55 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.65970967 |
| 56 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.65550802 |
| 57 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.63459998 |
| 58 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.60880506 |
| 59 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.59531326 |
| 60 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.59203242 |
| 61 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.59094245 |
| 62 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.58796315 |
| 63 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.55515871 |
| 64 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.54156911 |
| 65 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.52575483 |
| 66 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.52121176 |
| 67 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.50255548 |
| 68 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.49297896 |
| 69 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.47442763 |
| 70 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.47393293 |
| 71 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.45827932 |
| 72 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45407486 |
| 73 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.45163926 |
| 74 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.44621164 |
| 75 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.43863680 |
| 76 | P300_19829295_ChIP-Seq_ESCs_Human | 1.43544376 |
| 77 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42500498 |
| 78 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38615832 |
| 79 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.38150594 |
| 80 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.37453121 |
| 81 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.36319841 |
| 82 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.34770907 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33660262 |
| 84 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.32101271 |
| 85 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.30835482 |
| 86 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.30104025 |
| 87 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.29585288 |
| 88 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.29416171 |
| 89 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.26685784 |
| 90 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.25003494 |
| 91 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.24699293 |
| 92 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.24699293 |
| 93 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.24597332 |
| 94 | GATA3_26560356_Chip-Seq_TH1_Human | 1.24033291 |
| 95 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.23499450 |
| 96 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.22643411 |
| 97 | TP53_16413492_ChIP-PET_HCT116_Human | 1.21160483 |
| 98 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.20797470 |
| 99 | TCF4_23295773_ChIP-Seq_U87_Human | 1.20604212 |
| 100 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.19846463 |
| 101 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.19831312 |
| 102 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.18352319 |
| 103 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.17558948 |
| 104 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.16916970 |
| 105 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.16810695 |
| 106 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.16656749 |
| 107 | MYC_22102868_ChIP-Seq_BL_Human | 1.16593497 |
| 108 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.16588654 |
| 109 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.16578086 |
| 110 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.16387816 |
| 111 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.16156525 |
| 112 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.15829052 |
| 113 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.14861865 |
| 114 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.14413041 |
| 115 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.14109124 |
| 116 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.13976520 |
| 117 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.13760257 |
| 118 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.13628216 |
| 119 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.13171095 |
| 120 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.12922773 |
| 121 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.12801758 |
| 122 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.12553055 |
| 123 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.12542347 |
| 124 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.11041983 |
| 125 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.10050545 |
| 126 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09991403 |
| 127 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08121887 |
| 128 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07469229 |
| 129 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.06866588 |
| 130 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.06040132 |
| 131 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.05473543 |
| 132 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.04990630 |
| 133 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04710905 |
| 134 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.04033924 |
| 135 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03894047 |
| 136 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.03010993 |
| 137 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.02721107 |
| 138 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.02671976 |
| 139 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02197748 |
| 140 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.02120767 |
| 141 | STAT3_23295773_ChIP-Seq_U87_Human | 1.00959674 |
| 142 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00157119 |
| 143 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.99652815 |
| 144 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92287331 |
| 145 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.92265743 |
| 146 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91329300 |
| 147 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.91101249 |
| 148 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.89061890 |
| 149 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.88137787 |
| 150 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87271501 |
| 151 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.87212549 |
| 152 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86228748 |
| 153 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.85390497 |
| 154 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.85348817 |
| 155 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.84951095 |
| 156 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.81341092 |
| 157 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80708476 |
| 158 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80559383 |
| 159 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.79929009 |
| 160 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.78519749 |
| 161 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.77937580 |
| 162 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.76943039 |
| 163 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.76596388 |
| 164 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.76219172 |
| 165 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.75688274 |
| 166 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.73648270 |
| 167 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.73375538 |
| 168 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.72785205 |
| 169 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72385014 |
| 170 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.72325822 |
| 171 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.71801047 |
| 172 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.71174759 |
| 173 | SA1_27219007_Chip-Seq_Bcells_Human | 0.70663314 |
| 174 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.68978937 |
| 175 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.66208562 |
| 176 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.65749589 |
| 177 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.64256756 |
| 178 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.64053324 |
| 179 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.62732404 |
| 180 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.62044695 |
| 181 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.61880504 |
| 182 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.61098800 |
| 183 | P300_27268052_Chip-Seq_Bcells_Human | 0.61049892 |
| 184 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.61038083 |
| 185 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.60938797 |
| 186 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60798326 |
| 187 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.60376782 |
| 188 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.58442112 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 7.69301003 |
| 2 | MP0003136_yellow_coat_color | 7.19082817 |
| 3 | MP0005083_abnormal_biliary_tract | 5.11547227 |
| 4 | MP0003950_abnormal_plasma_membrane | 4.49617097 |
| 5 | MP0003763_abnormal_thymus_physiology | 4.44691418 |
| 6 | MP0001188_hyperpigmentation | 3.05459891 |
| 7 | MP0001873_stomach_inflammation | 3.03962000 |
| 8 | MP0005084_abnormal_gallbladder_morpholo | 3.01415867 |
| 9 | MP0009333_abnormal_splenocyte_physiolog | 2.98922603 |
| 10 | MP0001800_abnormal_humoral_immune | 2.94275468 |
| 11 | MP0002163_abnormal_gland_morphology | 2.83040020 |
| 12 | MP0004270_analgesia | 2.73417496 |
| 13 | MP0002723_abnormal_immune_serum | 2.63772714 |
| 14 | MP0003718_maternal_effect | 2.55342729 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.50266137 |
| 16 | MP0001819_abnormal_immune_cell | 2.42040957 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.36757926 |
| 18 | MP0010307_abnormal_tumor_latency | 2.35238450 |
| 19 | MP0002405_respiratory_system_inflammati | 2.34821050 |
| 20 | MP0003880_abnormal_central_pattern | 2.33022854 |
| 21 | MP0004381_abnormal_hair_follicle | 2.32890998 |
| 22 | MP0002398_abnormal_bone_marrow | 2.32140229 |
| 23 | MP0000566_synostosis | 2.26983829 |
| 24 | MP0003866_abnormal_defecation | 2.24655400 |
| 25 | MP0003183_abnormal_peptide_metabolism | 2.18528473 |
| 26 | MP0005379_endocrine/exocrine_gland_phen | 2.14285975 |
| 27 | MP0002722_abnormal_immune_system | 2.10077895 |
| 28 | MP0002933_joint_inflammation | 2.09006584 |
| 29 | MP0000716_abnormal_immune_system | 2.08948628 |
| 30 | MP0004145_abnormal_muscle_electrophysio | 2.07540509 |
| 31 | MP0002452_abnormal_antigen_presenting | 2.07229096 |
| 32 | MP0000703_abnormal_thymus_morphology | 2.06406310 |
| 33 | MP0003724_increased_susceptibility_to | 2.06201095 |
| 34 | MP0005409_darkened_coat_color | 2.02891633 |
| 35 | MP0010155_abnormal_intestine_physiology | 2.00130192 |
| 36 | MP0003690_abnormal_glial_cell | 1.97238757 |
| 37 | MP0005025_abnormal_response_to | 1.95409774 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.95123781 |
| 39 | MP0005387_immune_system_phenotype | 1.93885043 |
| 40 | MP0001790_abnormal_immune_system | 1.93885043 |
| 41 | MP0002877_abnormal_melanocyte_morpholog | 1.92638452 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.92570176 |
| 43 | MP0004782_abnormal_surfactant_physiolog | 1.90935453 |
| 44 | MP0003045_fibrosis | 1.87552298 |
| 45 | MP0001486_abnormal_startle_reflex | 1.86826620 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 1.84295852 |
| 47 | MP0005310_abnormal_salivary_gland | 1.83972545 |
| 48 | MP0000920_abnormal_myelination | 1.79336081 |
| 49 | MP0005257_abnormal_intraocular_pressure | 1.74612369 |
| 50 | MP0003195_calcinosis | 1.68181253 |
| 51 | MP0003786_premature_aging | 1.66618661 |
| 52 | MP0002138_abnormal_hepatobiliary_system | 1.64538838 |
| 53 | MP0005171_absent_coat_pigmentation | 1.63670859 |
| 54 | MP0002429_abnormal_blood_cell | 1.63439475 |
| 55 | MP0002064_seizures | 1.61646743 |
| 56 | MP0000685_abnormal_immune_system | 1.60854382 |
| 57 | MP0001501_abnormal_sleep_pattern | 1.58274685 |
| 58 | MP0003075_altered_response_to | 1.56730428 |
| 59 | MP0001485_abnormal_pinna_reflex | 1.56092359 |
| 60 | MP0001845_abnormal_inflammatory_respons | 1.54823207 |
| 61 | MP0005165_increased_susceptibility_to | 1.53629437 |
| 62 | MP0001853_heart_inflammation | 1.51360924 |
| 63 | MP0001851_eye_inflammation | 1.46088515 |
| 64 | MP0009046_muscle_twitch | 1.45964134 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 1.45827901 |
| 66 | MP0002909_abnormal_adrenal_gland | 1.43737048 |
| 67 | MP0006292_abnormal_olfactory_placode | 1.41914970 |
| 68 | MP0003172_abnormal_lysosome_physiology | 1.41783851 |
| 69 | MP0009745_abnormal_behavioral_response | 1.40780140 |
| 70 | MP0001968_abnormal_touch/_nociception | 1.37747616 |
| 71 | MP0002638_abnormal_pupillary_reflex | 1.34698080 |
| 72 | MP0002396_abnormal_hematopoietic_system | 1.34238108 |
| 73 | MP0004185_abnormal_adipocyte_glucose | 1.31801369 |
| 74 | MP0002572_abnormal_emotion/affect_behav | 1.31131472 |
| 75 | MP0004947_skin_inflammation | 1.30581293 |
| 76 | MP0004043_abnormal_pH_regulation | 1.29483060 |
| 77 | MP0003959_abnormal_lean_body | 1.28463277 |
| 78 | MP0002272_abnormal_nervous_system | 1.28317873 |
| 79 | MP0009840_abnormal_foam_cell | 1.27102829 |
| 80 | MP0008004_abnormal_stomach_pH | 1.26772448 |
| 81 | MP0003635_abnormal_synaptic_transmissio | 1.21880187 |
| 82 | MP0008569_lethality_at_weaning | 1.21447991 |
| 83 | MP0001661_extended_life_span | 1.21432440 |
| 84 | MP0005551_abnormal_eye_electrophysiolog | 1.20732767 |
| 85 | MP0001664_abnormal_digestion | 1.17866193 |
| 86 | MP0002734_abnormal_mechanical_nocicepti | 1.16262388 |
| 87 | MP0005365_abnormal_bile_salt | 1.16048459 |
| 88 | MP0003329_amyloid_beta_deposits | 1.13695760 |
| 89 | MP0008469_abnormal_protein_level | 1.11006934 |
| 90 | MP0004134_abnormal_chest_morphology | 1.10685986 |
| 91 | MP0005645_abnormal_hypothalamus_physiol | 1.08310527 |
| 92 | MP0003634_abnormal_glial_cell | 1.07415635 |
| 93 | MP0003448_altered_tumor_morphology | 1.06246866 |
| 94 | MP0002557_abnormal_social/conspecific_i | 1.05514106 |
| 95 | MP0002736_abnormal_nociception_after | 1.04266768 |
| 96 | MP0001502_abnormal_circadian_rhythm | 1.01192943 |
| 97 | MP0004147_increased_porphyrin_level | 1.01140064 |
| 98 | MP0000858_altered_metastatic_potential | 1.00343300 |
| 99 | MP0004742_abnormal_vestibular_system | 0.99941903 |
| 100 | MP0000372_irregular_coat_pigmentation | 0.98824955 |
| 101 | MP0005647_abnormal_sex_gland | 0.98699409 |
| 102 | MP0001324_abnormal_eye_pigmentation | 0.98482336 |
| 103 | MP0002063_abnormal_learning/memory/cond | 0.98373365 |
| 104 | MP0003436_decreased_susceptibility_to | 0.97511330 |
| 105 | MP0001348_abnormal_lacrimal_gland | 0.96364690 |
| 106 | MP0003633_abnormal_nervous_system | 0.96319591 |
| 107 | MP0005253_abnormal_eye_physiology | 0.94974074 |
| 108 | MP0002067_abnormal_sensory_capabilities | 0.94777969 |
| 109 | MP0005058_abnormal_lysosome_morphology | 0.90417746 |
| 110 | MP0003943_abnormal_hepatobiliary_system | 0.90376517 |
| 111 | MP0000778_abnormal_nervous_system | 0.88783807 |
| 112 | MP0003631_nervous_system_phenotype | 0.87603056 |
| 113 | MP0004484_altered_response_of | 0.85304359 |
| 114 | MP0009765_abnormal_xenobiotic_induced | 0.85103538 |
| 115 | MP0005174_abnormal_tail_pigmentation | 0.84910129 |
| 116 | MP0002009_preneoplasia | 0.83945239 |
| 117 | MP0002419_abnormal_innate_immunity | 0.83893965 |
| 118 | MP0003938_abnormal_ear_development | 0.83703738 |
| 119 | MP0003638_abnormal_response/metabolism_ | 0.83191020 |
| 120 | MP0001963_abnormal_hearing_physiology | 0.83011910 |
| 121 | MP0001727_abnormal_embryo_implantation | 0.82621496 |
| 122 | MP0000569_abnormal_digit_pigmentation | 0.82604490 |
| 123 | MP0000604_amyloidosis | 0.82111494 |
| 124 | MP0004272_abnormal_basement_membrane | 0.81680974 |
| 125 | MP0004142_abnormal_muscle_tone | 0.80050447 |
| 126 | MP0002882_abnormal_neuron_morphology | 0.79032273 |
| 127 | MP0003300_gastrointestinal_ulcer | 0.78116793 |
| 128 | MP0005410_abnormal_fertilization | 0.77880726 |
| 129 | MP0002069_abnormal_eating/drinking_beha | 0.77231782 |
| 130 | MP0008873_increased_physiological_sensi | 0.76583322 |
| 131 | MP0002229_neurodegeneration | 0.75742644 |
| 132 | MP0003632_abnormal_nervous_system | 0.75409258 |
| 133 | MP0005332_abnormal_amino_acid | 0.75356470 |
| 134 | MP0006138_congestive_heart_failure | 0.74486091 |
| 135 | MP0004859_abnormal_synaptic_plasticity | 0.74321042 |
| 136 | MP0005166_decreased_susceptibility_to | 0.74303584 |
| 137 | MP0009763_increased_sensitivity_to | 0.73534910 |
| 138 | MP0002148_abnormal_hypersensitivity_rea | 0.72788147 |
| 139 | MP0002653_abnormal_ependyma_morphology | 0.72569635 |
| 140 | MP0002160_abnormal_reproductive_system | 0.72172564 |
| 141 | MP0002066_abnormal_motor_capabilities/c | 0.70602026 |
| 142 | MP0002019_abnormal_tumor_incidence | 0.70376575 |
| 143 | MP0002693_abnormal_pancreas_physiology | 0.70371265 |
| 144 | MP0009785_altered_susceptibility_to | 0.70070286 |
| 145 | MP0001177_atelectasis | 0.69790306 |
| 146 | MP0002166_altered_tumor_susceptibility | 0.69744917 |
| 147 | MP0005377_hearing/vestibular/ear_phenot | 0.69284759 |
| 148 | MP0003878_abnormal_ear_physiology | 0.69284759 |
| 149 | MP0000462_abnormal_digestive_system | 0.69029183 |
| 150 | MP0003137_abnormal_impulse_conducting | 0.68617569 |
| 151 | MP0002102_abnormal_ear_morphology | 0.67380197 |
| 152 | MP0002733_abnormal_thermal_nociception | 0.67206742 |
| 153 | MP0002876_abnormal_thyroid_physiology | 0.66604647 |
| 154 | MP0005670_abnormal_white_adipose | 0.66158423 |
| 155 | MP0001529_abnormal_vocalization | 0.65732052 |
| 156 | MP0005085_abnormal_gallbladder_physiolo | 0.65402014 |
| 157 | MP0009764_decreased_sensitivity_to | 0.63765152 |
| 158 | MP0005000_abnormal_immune_tolerance | 0.63267055 |
| 159 | MP0001905_abnormal_dopamine_level | 0.62726422 |
| 160 | MP0009379_abnormal_foot_pigmentation | 0.62470461 |
| 161 | MP0009643_abnormal_urine_homeostasis | 0.62160282 |
| 162 | MP0005595_abnormal_vascular_smooth | 0.60194453 |
| 163 | MP0008260_abnormal_autophagy | 0.59650818 |
| 164 | MP0000015_abnormal_ear_pigmentation | 0.59629013 |
| 165 | MP0002752_abnormal_somatic_nervous | 0.59378000 |
| 166 | MP0006082_CNS_inflammation | 0.58835983 |
| 167 | MP0005075_abnormal_melanosome_morpholog | 0.58649497 |
| 168 | MP0000516_abnormal_urinary_system | 0.58490372 |
| 169 | MP0005367_renal/urinary_system_phenotyp | 0.58490372 |
| 170 | MP0004130_abnormal_muscle_cell | 0.58264692 |
| 171 | MP0000249_abnormal_blood_vessel | 0.58214138 |
| 172 | MP0004924_abnormal_behavior | 0.56265396 |
| 173 | MP0008007_abnormal_cellular_replicative | 0.56260580 |
| 174 | MP0002136_abnormal_kidney_physiology | 0.55568365 |
| 175 | MP0001191_abnormal_skin_condition | 0.51301909 |
| 176 | MP0003646_muscle_fatigue | 0.50454518 |
| 177 | MP0001986_abnormal_taste_sensitivity | 0.50206542 |
| 178 | MP0003111_abnormal_nucleus_morphology | 0.49895641 |
| 179 | MP0002083_premature_death | 0.49877887 |
| 180 | MP0001243_abnormal_dermal_layer | 0.49706000 |
| 181 | MP0005666_abnormal_adipose_tissue | 0.47800375 |
| 182 | MP0001984_abnormal_olfaction | 0.45275952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of T cell number (HP:0011839) | 8.41466358 |
| 2 | T lymphocytopenia (HP:0005403) | 8.03259562 |
| 3 | Increased IgM level (HP:0003496) | 5.94185099 |
| 4 | Autoimmune hemolytic anemia (HP:0001890) | 5.33320253 |
| 5 | Chronic diarrhea (HP:0002028) | 5.23750258 |
| 6 | Abnormality of T cells (HP:0002843) | 5.08091775 |
| 7 | Hypoproteinemia (HP:0003075) | 4.86399768 |
| 8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.61697408 |
| 9 | Visual hallucinations (HP:0002367) | 4.22066374 |
| 10 | Neurofibrillary tangles (HP:0002185) | 4.10711029 |
| 11 | Severe combined immunodeficiency (HP:0004430) | 4.07678426 |
| 12 | Abnormality of the prostate (HP:0008775) | 4.05893641 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 4.04275865 |
| 14 | Autoimmune thrombocytopenia (HP:0001973) | 3.99680305 |
| 15 | IgG deficiency (HP:0004315) | 3.91753320 |
| 16 | Recurrent bronchitis (HP:0002837) | 3.84503308 |
| 17 | Aplastic anemia (HP:0001915) | 3.76638805 |
| 18 | Ankle clonus (HP:0011448) | 3.67203316 |
| 19 | Abnormality of eosinophils (HP:0001879) | 3.63833533 |
| 20 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 3.63532578 |
| 21 | J-shaped sella turcica (HP:0002680) | 3.63450962 |
| 22 | Hypoplasia of the thymus (HP:0000778) | 3.60929451 |
| 23 | Absent septum pellucidum (HP:0001331) | 3.57424640 |
| 24 | Fibular aplasia (HP:0002990) | 3.45605460 |
| 25 | Ureteral stenosis (HP:0000071) | 3.40202232 |
| 26 | Abnormality of the corticospinal tract (HP:0002492) | 3.38543858 |
| 27 | Optic nerve hypoplasia (HP:0000609) | 3.31156799 |
| 28 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.28611123 |
| 29 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.28611123 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 3.28597942 |
| 31 | Obstructive lung disease (HP:0006536) | 3.28597942 |
| 32 | Granulocytopenia (HP:0001913) | 3.27218550 |
| 33 | Clumsiness (HP:0002312) | 3.26673013 |
| 34 | Meningitis (HP:0001287) | 3.25669275 |
| 35 | Abnormality of B cell number (HP:0010975) | 3.19269622 |
| 36 | Combined immunodeficiency (HP:0005387) | 3.19029932 |
| 37 | Thyroiditis (HP:0100646) | 3.15748260 |
| 38 | Ureteral obstruction (HP:0006000) | 3.13945725 |
| 39 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.13155353 |
| 40 | Vasculitis (HP:0002633) | 3.13155022 |
| 41 | Hemiparesis (HP:0001269) | 3.08725007 |
| 42 | Eosinophilia (HP:0001880) | 3.06341561 |
| 43 | Protruding tongue (HP:0010808) | 3.05256587 |
| 44 | Abnormality of the septum pellucidum (HP:0007375) | 3.02388480 |
| 45 | Hyperventilation (HP:0002883) | 3.01615968 |
| 46 | Recurrent viral infections (HP:0004429) | 3.00688593 |
| 47 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.99472746 |
| 48 | Stomach cancer (HP:0012126) | 2.98734822 |
| 49 | Short tibia (HP:0005736) | 2.92019397 |
| 50 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.90785485 |
| 51 | Recurrent cutaneous fungal infections (HP:0011370) | 2.90785485 |
| 52 | Encephalitis (HP:0002383) | 2.90681471 |
| 53 | Focal motor seizures (HP:0011153) | 2.90380818 |
| 54 | Recurrent fungal infections (HP:0002841) | 2.89684967 |
| 55 | Chest pain (HP:0100749) | 2.89574277 |
| 56 | Hemiplegia (HP:0002301) | 2.87960991 |
| 57 | IgA deficiency (HP:0002720) | 2.87519551 |
| 58 | Epileptic encephalopathy (HP:0200134) | 2.82543873 |
| 59 | Abnormality of T cell physiology (HP:0011840) | 2.82409546 |
| 60 | Gangrene (HP:0100758) | 2.80672629 |
| 61 | Pustule (HP:0200039) | 2.75361241 |
| 62 | Carpal bone hypoplasia (HP:0001498) | 2.73644882 |
| 63 | Abnormality of binocular vision (HP:0011514) | 2.72743726 |
| 64 | Diplopia (HP:0000651) | 2.72743726 |
| 65 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.70466717 |
| 66 | Hemoptysis (HP:0002105) | 2.70162649 |
| 67 | Lymphopenia (HP:0001888) | 2.69673414 |
| 68 | Axonal loss (HP:0003447) | 2.69438665 |
| 69 | Gait imbalance (HP:0002141) | 2.69241176 |
| 70 | Pulmonary infiltrates (HP:0002113) | 2.68675746 |
| 71 | Leukocytosis (HP:0001974) | 2.68241975 |
| 72 | Dysmetria (HP:0001310) | 2.67709347 |
| 73 | Mutism (HP:0002300) | 2.65352855 |
| 74 | Abnormality of male internal genitalia (HP:0000022) | 2.64118815 |
| 75 | Abnormal sex determination (HP:0012244) | 2.62123736 |
| 76 | Sex reversal (HP:0012245) | 2.62123736 |
| 77 | Termporal pattern (HP:0011008) | 2.61186670 |
| 78 | Insidious onset (HP:0003587) | 2.61186670 |
| 79 | Neuronal loss in central nervous system (HP:0002529) | 2.60577688 |
| 80 | Confusion (HP:0001289) | 2.59575164 |
| 81 | Adactyly (HP:0009776) | 2.58594294 |
| 82 | Stomatitis (HP:0010280) | 2.57717506 |
| 83 | Hyperglycinemia (HP:0002154) | 2.55738420 |
| 84 | Joint swelling (HP:0001386) | 2.52680310 |
| 85 | Septo-optic dysplasia (HP:0100842) | 2.52003164 |
| 86 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.51780128 |
| 87 | Cerebral inclusion bodies (HP:0100314) | 2.50695854 |
| 88 | Lymphoma (HP:0002665) | 2.50610052 |
| 89 | Hyperglycinuria (HP:0003108) | 2.49929569 |
| 90 | Hypoplasia of the uterus (HP:0000013) | 2.49647564 |
| 91 | Absence seizures (HP:0002121) | 2.48446736 |
| 92 | Myositis (HP:0100614) | 2.47658821 |
| 93 | Congenital primary aphakia (HP:0007707) | 2.45464501 |
| 94 | Progressive external ophthalmoplegia (HP:0000590) | 2.43799051 |
| 95 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.39620608 |
| 96 | Hypergammaglobulinemia (HP:0010702) | 2.36233935 |
| 97 | Chronic hepatic failure (HP:0100626) | 2.36044614 |
| 98 | Tetraplegia (HP:0002445) | 2.35379839 |
| 99 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.34205595 |
| 100 | Abnormality of glycine metabolism (HP:0010895) | 2.34205595 |
| 101 | Agammaglobulinemia (HP:0004432) | 2.31173973 |
| 102 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.30488080 |
| 103 | Urinary urgency (HP:0000012) | 2.30384306 |
| 104 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.28880007 |
| 105 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.28880007 |
| 106 | Prolonged neonatal jaundice (HP:0006579) | 2.27295139 |
| 107 | Bronchitis (HP:0012387) | 2.27079122 |
| 108 | 3-Methylglutaconic aciduria (HP:0003535) | 2.26895067 |
| 109 | Blue irides (HP:0000635) | 2.25961798 |
| 110 | Synostosis involving the elbow (HP:0003938) | 2.25551576 |
| 111 | Humeroradial synostosis (HP:0003041) | 2.25551576 |
| 112 | Drooling (HP:0002307) | 2.25516643 |
| 113 | Excessive salivation (HP:0003781) | 2.25516643 |
| 114 | Pulmonary embolism (HP:0002204) | 2.25246929 |
| 115 | Abnormality of macrophages (HP:0004311) | 2.23652703 |
| 116 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.23200678 |
| 117 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.23200678 |
| 118 | Abnormality of glycolipid metabolism (HP:0010969) | 2.23200678 |
| 119 | Recurrent skin infections (HP:0001581) | 2.22434158 |
| 120 | Medial flaring of the eyebrow (HP:0010747) | 2.20607971 |
| 121 | Pulmonary fibrosis (HP:0002206) | 2.20514707 |
| 122 | Constricted visual fields (HP:0001133) | 2.20504342 |
| 123 | Duplicated collecting system (HP:0000081) | 2.19600970 |
| 124 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.19243056 |
| 125 | Abnormality of DNA repair (HP:0003254) | 2.18644753 |
| 126 | Abnormality of the pleura (HP:0002103) | 2.16424631 |
| 127 | Urinary incontinence (HP:0000020) | 2.15798957 |
| 128 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.15505870 |
| 129 | Abnormality of the 2nd finger (HP:0004100) | 2.15180738 |
| 130 | Abnormality of the alveolar ridges (HP:0006477) | 2.14375125 |
| 131 | Recurrent bacterial skin infections (HP:0005406) | 2.12385989 |
| 132 | Joint hemorrhage (HP:0005261) | 2.10241118 |
| 133 | External ophthalmoplegia (HP:0000544) | 2.09950619 |
| 134 | Retinal dysplasia (HP:0007973) | 2.09102461 |
| 135 | Type II lissencephaly (HP:0007260) | 2.08197007 |
| 136 | Abnormality of the common coagulation pathway (HP:0010990) | 2.08172367 |
| 137 | Optic neuritis (HP:0100653) | 2.07340084 |
| 138 | Retrobulbar optic neuritis (HP:0100654) | 2.07340084 |
| 139 | Hypochromic anemia (HP:0001931) | 2.06179163 |
| 140 | Melanoma (HP:0002861) | 2.05682223 |
| 141 | Nephrogenic diabetes insipidus (HP:0009806) | 2.02583790 |
| 142 | Type I transferrin isoform profile (HP:0003642) | 2.02505078 |
| 143 | Exercise-induced myalgia (HP:0003738) | 2.00804438 |
| 144 | Recurrent abscess formation (HP:0002722) | 1.99928659 |
| 145 | Metabolic alkalosis (HP:0200114) | 1.99629053 |
| 146 | Recurrent otitis media (HP:0000403) | 1.99444054 |
| 147 | Conical tooth (HP:0000698) | 1.98983096 |
| 148 | Gaze-evoked nystagmus (HP:0000640) | 1.98273364 |
| 149 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.96910433 |
| 150 | Progressive inability to walk (HP:0002505) | 1.96793423 |
| 151 | Dislocated radial head (HP:0003083) | 1.96732652 |
| 152 | Autoamputation (HP:0001218) | 1.96138859 |
| 153 | Cortical visual impairment (HP:0100704) | 1.95877548 |
| 154 | Abnormal albumin level (HP:0012116) | 1.95857673 |
| 155 | Hypoalbuminemia (HP:0003073) | 1.95857673 |
| 156 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.94972291 |
| 157 | Supranuclear gaze palsy (HP:0000605) | 1.93698727 |
| 158 | Type I diabetes mellitus (HP:0100651) | 1.93431316 |
| 159 | Fatigue (HP:0012378) | 1.91158195 |
| 160 | Abnormality of the radial head (HP:0003995) | 1.90853982 |
| 161 | Panhypogammaglobulinemia (HP:0003139) | 1.89762008 |
| 162 | Action tremor (HP:0002345) | 1.89332433 |
| 163 | Abnormality of the renal collecting system (HP:0004742) | 1.88961035 |
| 164 | Hypercortisolism (HP:0001578) | 1.88616570 |
| 165 | Focal seizures (HP:0007359) | 1.88552499 |
| 166 | Restlessness (HP:0000711) | 1.87572982 |
| 167 | Clonus (HP:0002169) | 1.87530119 |
| 168 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.87093701 |
| 169 | Skin rash (HP:0000988) | 1.86846537 |
| 170 | Periorbital edema (HP:0100539) | 1.86001699 |
| 171 | True hermaphroditism (HP:0010459) | 1.84859911 |
| 172 | Abnormal auditory evoked potentials (HP:0006958) | 1.83957845 |
| 173 | Broad-based gait (HP:0002136) | 1.82917864 |
| 174 | Prolonged partial thromboplastin time (HP:0003645) | 1.81410594 |
| 175 | Agitation (HP:0000713) | 1.81208609 |
| 176 | Facial edema (HP:0000282) | 1.80941896 |
| 177 | Neuroendocrine neoplasm (HP:0100634) | 1.79878059 |
| 178 | Mediastinal lymphadenopathy (HP:0100721) | 1.79338346 |
| 179 | Zonular cataract (HP:0010920) | 1.78994401 |
| 180 | Glomerulopathy (HP:0100820) | 1.77872391 |
| 181 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.77795971 |
| 182 | Abnormal pancreas size (HP:0012094) | 1.77693638 |
| 183 | Dialeptic seizures (HP:0011146) | 1.77523086 |
| 184 | Progressive cerebellar ataxia (HP:0002073) | 1.76281944 |
| 185 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.75674919 |
| 186 | Peripheral demyelination (HP:0011096) | 1.75337280 |
| 187 | Generalized myoclonic seizures (HP:0002123) | 1.75055692 |
| 188 | Dyschromatopsia (HP:0007641) | 1.74949696 |
| 189 | Anhidrosis (HP:0000970) | 1.74907636 |
| 190 | Abnormality of salivation (HP:0100755) | 1.73451284 |
| 191 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.72883703 |
| 192 | Orchitis (HP:0100796) | 1.71659266 |
| 193 | Leiomyosarcoma (HP:0100243) | 1.71095014 |
| 194 | Uterine leiomyosarcoma (HP:0002891) | 1.71095014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 7.74484661 |
| 2 | CASK | 5.34713356 |
| 3 | CLK1 | 4.54276375 |
| 4 | KDR | 3.83982225 |
| 5 | STK39 | 3.75783476 |
| 6 | MAP4K1 | 3.05045772 |
| 7 | ITK | 2.79611102 |
| 8 | GRK7 | 2.64341083 |
| 9 | BMX | 2.60532519 |
| 10 | MAPKAPK5 | 2.51582195 |
| 11 | FES | 2.44423275 |
| 12 | NME1 | 2.33514918 |
| 13 | ZAP70 | 2.21799066 |
| 14 | MAPK15 | 2.08513021 |
| 15 | SYK | 1.95214984 |
| 16 | IRAK2 | 1.94586923 |
| 17 | WNK4 | 1.84002387 |
| 18 | EPHA4 | 1.80004789 |
| 19 | OXSR1 | 1.78113797 |
| 20 | TEC | 1.72176612 |
| 21 | UHMK1 | 1.69178211 |
| 22 | MAP3K12 | 1.61848141 |
| 23 | ADRBK2 | 1.60169060 |
| 24 | IRAK1 | 1.59369771 |
| 25 | TNIK | 1.57583057 |
| 26 | LCK | 1.56763029 |
| 27 | TYRO3 | 1.56573793 |
| 28 | CAMK1D | 1.55432501 |
| 29 | MAP3K14 | 1.44029332 |
| 30 | FGR | 1.43555350 |
| 31 | MAPK13 | 1.37965623 |
| 32 | IRAK4 | 1.37286575 |
| 33 | FRK | 1.34656871 |
| 34 | GRK1 | 1.33645782 |
| 35 | MAPKAPK3 | 1.33021279 |
| 36 | TRIM28 | 1.30732735 |
| 37 | MATK | 1.27133690 |
| 38 | BCKDK | 1.26874545 |
| 39 | ZAK | 1.25690165 |
| 40 | BTK | 1.21541772 |
| 41 | PDGFRB | 1.21492595 |
| 42 | PBK | 1.18834094 |
| 43 | TBK1 | 1.18603797 |
| 44 | MAPK12 | 1.17083609 |
| 45 | DAPK1 | 1.14055071 |
| 46 | WNK1 | 1.11952583 |
| 47 | BLK | 1.11883957 |
| 48 | RIPK4 | 1.04662519 |
| 49 | TRPM7 | 1.03337713 |
| 50 | VRK2 | 1.02019164 |
| 51 | HIPK2 | 1.01896866 |
| 52 | TAOK3 | 0.98617646 |
| 53 | PIM2 | 0.97697668 |
| 54 | PRKCE | 0.97080000 |
| 55 | EPHB1 | 0.96647617 |
| 56 | CAMK1G | 0.96527864 |
| 57 | IRAK3 | 0.95083785 |
| 58 | MAP3K10 | 0.94261055 |
| 59 | CSF1R | 0.92964118 |
| 60 | JAK2 | 0.88524801 |
| 61 | NEK9 | 0.85861639 |
| 62 | LYN | 0.84854996 |
| 63 | EEF2K | 0.82125536 |
| 64 | ALK | 0.80896223 |
| 65 | PDK2 | 0.78544964 |
| 66 | NEK1 | 0.77344077 |
| 67 | WNK3 | 0.76234662 |
| 68 | IKBKB | 0.74365655 |
| 69 | BMPR2 | 0.73042483 |
| 70 | SMG1 | 0.72990514 |
| 71 | EPHA3 | 0.72345842 |
| 72 | DYRK3 | 0.71683908 |
| 73 | JAK1 | 0.69968914 |
| 74 | CAMK2B | 0.69366180 |
| 75 | PHKG2 | 0.67539093 |
| 76 | PHKG1 | 0.67539093 |
| 77 | TESK2 | 0.66914640 |
| 78 | BCR | 0.66242341 |
| 79 | MET | 0.66188278 |
| 80 | IKBKE | 0.65077001 |
| 81 | CAMKK1 | 0.64663550 |
| 82 | NTRK3 | 0.64158425 |
| 83 | SGK494 | 0.63141761 |
| 84 | SGK223 | 0.63141761 |
| 85 | CAMK2A | 0.63069920 |
| 86 | MAP3K7 | 0.63000476 |
| 87 | PINK1 | 0.62609986 |
| 88 | PDK1 | 0.61198823 |
| 89 | DAPK2 | 0.58893933 |
| 90 | NTRK1 | 0.58141882 |
| 91 | GRK6 | 0.58072015 |
| 92 | PIK3CG | 0.57537023 |
| 93 | PRPF4B | 0.57160397 |
| 94 | NUAK1 | 0.55192249 |
| 95 | MYLK | 0.55180534 |
| 96 | MAPK4 | 0.54446675 |
| 97 | MAP2K2 | 0.53868209 |
| 98 | TXK | 0.53830194 |
| 99 | TYK2 | 0.53679550 |
| 100 | MAPKAPK2 | 0.52450611 |
| 101 | VRK1 | 0.51302372 |
| 102 | ARAF | 0.50720684 |
| 103 | EIF2AK3 | 0.50579844 |
| 104 | TGFBR2 | 0.49602963 |
| 105 | PRKCQ | 0.48347984 |
| 106 | CDK19 | 0.48091994 |
| 107 | PIM1 | 0.47946405 |
| 108 | CDK3 | 0.47224632 |
| 109 | BUB1 | 0.47033012 |
| 110 | PRKD2 | 0.47027878 |
| 111 | MAPK3 | 0.45101841 |
| 112 | YES1 | 0.44951433 |
| 113 | MAPK11 | 0.44380978 |
| 114 | EIF2AK2 | 0.44373447 |
| 115 | CDK5 | 0.43912277 |
| 116 | NLK | 0.43688670 |
| 117 | SGK2 | 0.43632016 |
| 118 | GRK5 | 0.41380025 |
| 119 | TSSK6 | 0.41231832 |
| 120 | MST4 | 0.40633361 |
| 121 | SGK1 | 0.39851104 |
| 122 | HCK | 0.39310755 |
| 123 | MAPK7 | 0.39032536 |
| 124 | PASK | 0.37221112 |
| 125 | RPS6KA5 | 0.36429477 |
| 126 | PRKCG | 0.35981936 |
| 127 | CAMK2D | 0.35822975 |
| 128 | JAK3 | 0.35749883 |
| 129 | MST1R | 0.34244162 |
| 130 | CSK | 0.33816385 |
| 131 | RET | 0.33522398 |
| 132 | PIK3CA | 0.32030446 |
| 133 | MARK1 | 0.29936682 |
| 134 | MKNK1 | 0.29623788 |
| 135 | MAP3K11 | 0.29540224 |
| 136 | IGF1R | 0.27536853 |
| 137 | PRKACA | 0.27293775 |
| 138 | ROCK2 | 0.26739143 |
| 139 | CAMK2G | 0.26590957 |
| 140 | CAMK1 | 0.25055193 |
| 141 | ROCK1 | 0.24439444 |
| 142 | NME2 | 0.24421856 |
| 143 | LMTK2 | 0.24274433 |
| 144 | MAP2K6 | 0.24252686 |
| 145 | GSK3A | 0.24199823 |
| 146 | ADRBK1 | 0.24199204 |
| 147 | PRKCD | 0.24164197 |
| 148 | MELK | 0.23321321 |
| 149 | INSR | 0.23227689 |
| 150 | DDR2 | 0.22640860 |
| 151 | FGFR2 | 0.22506430 |
| 152 | PDPK1 | 0.22185109 |
| 153 | MARK3 | 0.21656437 |
| 154 | CSNK1A1 | 0.21577320 |
| 155 | FYN | 0.21168274 |
| 156 | PRKCA | 0.20601721 |
| 157 | MAPK9 | 0.20330584 |
| 158 | MAP3K5 | 0.20290757 |
| 159 | STK10 | 0.19948014 |
| 160 | ABL1 | 0.19657666 |
| 161 | PKN1 | 0.19320297 |
| 162 | BMPR1B | 0.17531412 |
| 163 | NTRK2 | 0.16975002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.78996188 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.36444782 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.87652815 |
| 4 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 3.85663025 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.35651257 |
| 6 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.19810491 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.93144694 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.62209454 |
| 9 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.60379953 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.57721958 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.30793045 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.26611100 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.24737161 |
| 14 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.17213931 |
| 15 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.13701130 |
| 16 | Nicotine addiction_Homo sapiens_hsa05033 | 2.11479503 |
| 17 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 2.09358402 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.96907442 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 1.87280078 |
| 20 | GABAergic synapse_Homo sapiens_hsa04727 | 1.83737211 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.82451847 |
| 22 | Proteasome_Homo sapiens_hsa03050 | 1.81729102 |
| 23 | Morphine addiction_Homo sapiens_hsa05032 | 1.78786644 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.78641948 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.77975612 |
| 26 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.76682164 |
| 27 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.72584718 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.72528738 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.72175140 |
| 30 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.72026286 |
| 31 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.70583056 |
| 32 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.69404491 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.66385695 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.62924414 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.61436074 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.58920035 |
| 37 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.56856409 |
| 38 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.51409970 |
| 39 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.50776277 |
| 40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.47995472 |
| 41 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.45793461 |
| 42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.45043159 |
| 43 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.43213968 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 1.41601926 |
| 45 | Circadian entrainment_Homo sapiens_hsa04713 | 1.34547674 |
| 46 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.33897299 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33107078 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.33092178 |
| 49 | Leishmaniasis_Homo sapiens_hsa05140 | 1.22991746 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.22608744 |
| 51 | Taste transduction_Homo sapiens_hsa04742 | 1.21474170 |
| 52 | Insulin secretion_Homo sapiens_hsa04911 | 1.21462401 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.19306728 |
| 54 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.18529013 |
| 55 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.16771054 |
| 56 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.13231723 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11608541 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.10241633 |
| 59 | Protein export_Homo sapiens_hsa03060 | 1.06843496 |
| 60 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.05977560 |
| 61 | Long-term depression_Homo sapiens_hsa04730 | 1.03908820 |
| 62 | Malaria_Homo sapiens_hsa05144 | 1.03706949 |
| 63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.99677162 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.97011337 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 0.94874988 |
| 66 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.94663331 |
| 67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93554658 |
| 68 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92198933 |
| 69 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.91918858 |
| 70 | Peroxisome_Homo sapiens_hsa04146 | 0.89259984 |
| 71 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.87866148 |
| 72 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.87024005 |
| 73 | Cocaine addiction_Homo sapiens_hsa05030 | 0.85783463 |
| 74 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.84795744 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.83121131 |
| 76 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.82885071 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82502816 |
| 78 | HTLV-I infection_Homo sapiens_hsa05166 | 0.82366933 |
| 79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.82130023 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80910601 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78936782 |
| 82 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.75337593 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74565018 |
| 84 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.74564476 |
| 85 | Influenza A_Homo sapiens_hsa05164 | 0.74123079 |
| 86 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.72683923 |
| 87 | Pertussis_Homo sapiens_hsa05133 | 0.72052185 |
| 88 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.69333068 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68739193 |
| 90 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68270784 |
| 91 | Lysosome_Homo sapiens_hsa04142 | 0.67683424 |
| 92 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.66482423 |
| 93 | Melanogenesis_Homo sapiens_hsa04916 | 0.66102885 |
| 94 | Phagosome_Homo sapiens_hsa04145 | 0.65094735 |
| 95 | Mineral absorption_Homo sapiens_hsa04978 | 0.64798865 |
| 96 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.64491891 |
| 97 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.64330078 |
| 98 | Shigellosis_Homo sapiens_hsa05131 | 0.64325983 |
| 99 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63984009 |
| 100 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.63939103 |
| 101 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.61898899 |
| 102 | Tight junction_Homo sapiens_hsa04530 | 0.60751586 |
| 103 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60659904 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59306034 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58939285 |
| 106 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56566854 |
| 107 | Legionellosis_Homo sapiens_hsa05134 | 0.55775734 |
| 108 | Parkinsons disease_Homo sapiens_hsa05012 | 0.55195727 |
| 109 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.52866910 |
| 110 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.50612842 |
| 111 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49987070 |
| 112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49440174 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49375216 |
| 114 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.48344966 |
| 115 | Renin secretion_Homo sapiens_hsa04924 | 0.48092164 |
| 116 | Prion diseases_Homo sapiens_hsa05020 | 0.47520796 |
| 117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47091067 |
| 118 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.46589824 |
| 119 | ABC transporters_Homo sapiens_hsa02010 | 0.46381257 |
| 120 | Olfactory transduction_Homo sapiens_hsa04740 | 0.46089174 |
| 121 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45798185 |
| 122 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.45795818 |
| 123 | Salmonella infection_Homo sapiens_hsa05132 | 0.45681770 |
| 124 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44968624 |
| 125 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.44764143 |
| 126 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44298378 |
| 127 | Tuberculosis_Homo sapiens_hsa05152 | 0.43521139 |
| 128 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.43099716 |
| 129 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.42733804 |
| 130 | Hepatitis C_Homo sapiens_hsa05160 | 0.39086384 |
| 131 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.39015353 |
| 132 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.38453396 |
| 133 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.37656884 |
| 134 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.36880328 |
| 135 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36553043 |
| 136 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35865638 |
| 137 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.32906873 |
| 138 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32644621 |
| 139 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32378118 |
| 140 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.29955529 |
| 141 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.28512016 |
| 142 | Phototransduction_Homo sapiens_hsa04744 | 0.26783514 |
| 143 | Alzheimers disease_Homo sapiens_hsa05010 | 0.24486652 |
| 144 | Hepatitis B_Homo sapiens_hsa05161 | 0.22139605 |
| 145 | RNA polymerase_Homo sapiens_hsa03020 | 0.22053293 |
| 146 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.22004121 |
| 147 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.21398792 |
| 148 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.21217119 |
| 149 | Glioma_Homo sapiens_hsa05214 | 0.19343245 |
| 150 | Thyroid cancer_Homo sapiens_hsa05216 | 0.18635234 |
| 151 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.18526572 |
| 152 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.18442780 |
| 153 | Endocytosis_Homo sapiens_hsa04144 | 0.13661796 |
| 154 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.13088611 |
| 155 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.12541777 |
| 156 | Retinol metabolism_Homo sapiens_hsa00830 | 0.11739656 |
| 157 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.07561701 |
| 158 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.04307705 |
| 159 | Alcoholism_Homo sapiens_hsa05034 | 0.02966310 |
| 160 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.02823610 |
| 161 | Caffeine metabolism_Homo sapiens_hsa00232 | -0.0547013 |
| 162 | Mismatch repair_Homo sapiens_hsa03430 | -0.0494441 |
| 163 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | -0.0442917 |
| 164 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | -0.0352404 |
| 165 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0334786 |
| 166 | Viral carcinogenesis_Homo sapiens_hsa05203 | -0.0157222 |
| 167 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | -0.0042208 |

